Ajan Reginald
@AjanReginaldEntrepreneur & CEO @RoquefortTherap @Celixirltd. ExBCG, and Roche. Fulbright Scholar, Uni of Oxford, Harvard Business School and Kellogg. Personal opinions
Similar User
@RoquefortTherap
@liton476
@Rocky101062
@TobiasMPeterka
@CalimaEnergy
@eth_Ninja88
@Satoshicallsbr
@lake_joash
@Woodymatic1
@SWLFexploration
@JohnAnthonyF10
@milt_MD_PhD
We are progressing with the Company's near-term imperative, which remains, to complete meaningful partnerships with one or more Big Pharma companies #ROQ #siRNA #STAT6
Roquefort Therapeutics - STAT-6 siRNA Presentation at Advanced Therapy Development Congress #ROQ #siRNA #STAT6 londonstockexchange.com/news-article/R…
$ROQ Roquefort presentation reveals the biotech is a leader in emerging targeted treatment field tinyurl.com/22qg2e88 @roqueforttherap $ROQAF #ROQ #ROQAF
🎥 Our CEO @AjanReginald with Steve Darling from @proactive_UK on the promising results of our STAT-6 siRNA program #ROQ #Cancer #siRNA youtube.com/watch?v=716uRX…
Back in 2014, Novartis ditched its RNAi research, giving the lead scientist the first "courage award" for stopping bad projects!🤦♂️ Novartis ex-CEO Joseph Jimenez said at the time, "One of the reasons why spending in the pharmaceutical industry is so high is that many scientists…
#ROQ is actively pursuing an out-licensing deal with Big Pharma for its STAT-6 siRNA programme #ROQ believes that positive immunology results will enhance the existing positive oncology results & therefore strengthen the programme's attractiveness to potential licensees
Roquefort Therapeutics is pleased to announce its interim results for the six-month period ended 30 June 2024 londonstockexchange.com/news-article/R…
The Roquefort Therapeutics Board has the personal experience and a strong network from completing deals with Japan Big Pharma. We have initiated these discussions and will update the market in due course #ROQ #siRNA #Cancer #Biotech
The granted Japan patent allows the Company to access an accelerated route-to-market for promising cellular medicines in Japan. This may significantly increase the value of cellular medicines as this enables a cheaper and faster route to market. #ROQ #siRNA #Cancer #Biotech
Roquefort Therapeutics secures Japanese patent protection for MK technology; has big plans for the land of the rising sun @roqueforttherap #LSE #OTCQB #ROQ #ROQAF ow.ly/HZvr105JyOT
Roquefort Therapeutics is pleased to announce that the Japan Patent Office has granted the patent for its Mesodermal Killer ("MK") cell therapy. londonstockexchange.com/news-article/R…
$ROQ Roquefort Therapeutics secures Japanese patent protection for MK technology; has big plans for the land of the rising sun tinyurl.com/268y7xux @roqueforttherap $ROQAF #ROQ #ROQAF
Yes, quality and cost of manufacturing are important regulatory and commercial issues in novel modalities. But in addition, key strategic decisions like the indication selection and development program are not as straightforward (vs. NMEs / mABs)
When looking at companies with novel modalities, like cell therapy, investors need to pay even more attention to manufacturing & CMC There are not a lot of experts with these modalities & that matters to regulators #learnbiotechinvesting #biotech #investing #BiotechPrometheus
When looking at companies with novel modalities, like cell therapy, investors need to pay even more attention to manufacturing & CMC There are not a lot of experts with these modalities & that matters to regulators #learnbiotechinvesting #biotech #investing #BiotechPrometheus
The patent expirations are driving Big Pharma’s need to acquire new products. Approved products are scarce and expensive and so, most Big Pharma are buying Biotech comapnies with products in development. In Q1 2024, Oncology was the top therapy area for M&A deals in Q1 2024,…
🎥 Our CEO @AjanReginald joined Steve Darling from @proactive_UK to share the promising results of our STAT-6 siRNA program, demonstrating efficacy in a validated in vitro model of immunological disease. #ROQ #Cancer #siRNA youtube.com/watch?v=716uRX…
$ROQ Roquefort Therapeutics STAT-6 siRNA Shows Efficacy in Experimental Model, Pursues Out-Licensing Deal tinyurl.com/2y733weo @roqueforttherap $ROQAF #ROQ #ROQAF
#roq great results .. so undervalued. Roquefort Theraptcs. - STAT-6 siRNA Demonstrates Efficacy in Immunology #ROQ voxmarkets.co.uk/rns/announceme… #voxmarkets undefined
United States Trends
- 1. Tyson 458 B posts
- 2. $MAYO 12,7 B posts
- 3. #wompwomp 4.018 posts
- 4. Pence 54,4 B posts
- 5. Debbie 29,7 B posts
- 6. Kash 92,2 B posts
- 7. Dora 23,7 B posts
- 8. Whoopi 92,5 B posts
- 9. Ronaldo 146 B posts
- 10. Connor Williams 1.076 posts
- 11. The FBI 251 B posts
- 12. Mike Rogers 17,4 B posts
- 13. Iron Mike 19,2 B posts
- 14. #LetsBONK 12,4 B posts
- 15. Gabrielle Union 1.846 posts
- 16. National Energy Council 4.968 posts
- 17. #FursuitFriday 16,7 B posts
- 18. Pepsi 20,9 B posts
- 19. Laken Riley 57,4 B posts
- 20. AFCON 33 B posts
Who to follow
-
Roquefort Therapeutics
@RoquefortTherap -
Engr Ashraf
@liton476 -
Rocky101062
@Rocky101062 -
Tobias Matthias Peterka
@TobiasMPeterka -
Calima Energy
@CalimaEnergy -
mike
@eth_Ninja88 -
Satoshi Mineiro
@Satoshicallsbr -
Joash
@lake_joash -
Woodymatic
@Woodymatic1 -
Silver Wolf Exploration
@SWLFexploration -
John Anthony François
@JohnAnthonyF10 -
Milton Brown, MD, PhD
@milt_MD_PhD
Something went wrong.
Something went wrong.